Levoxyl and Psychotic disorder - a phase IV clinical study of FDA data

Summary:

Psychotic disorder is reported as a side effect among people who take Levoxyl (levothyroxine sodium), especially for people who are female, 50-59 old, also take Ambien, and have Fibromyalgia.

The phase IV clinical study analyzes which people have Psychotic disorder when taking Levoxyl. It is created by eHealthMe based on reports of 23,566 people who have side effects when taking Levoxyl from the FDA, and is updated regularly.

What is Levoxyl?

Levoxyl has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 25,178 Levoxyl users. Check the latest studies of Levoxyl.

What is Psychotic disorder?

Psychotic disorder is found to be associated with 1,233 drugs and 1,471 conditions by eHealthMe. Check the latest studies of Psychotic disorder.

On Jul, 11, 2026

23,566 people reported to have side effects when taking Levoxyl.
Among them, 30 people (0.13%) have Psychotic disorder.

Among these 30 people:

What is the gender of people who have Psychotic disorder when taking Levoxyl? *

female: 70 %
male: 30 %

What is the age of people who have Psychotic disorder when taking Levoxyl? *

What are other drugs people take besides Levoxyl? *

What are other side effects people have besides Psychotic disorder? *

Nausea (feeling of having an urge to vomit): 8 people, 26.67%
Abdominal Pain Upper: 6 people, 20.00%
Dizziness: 5 people, 16.67%
Agitation (state of anxiety or nervous excitement): 4 people, 13.33%
Weakness: 4 people, 13.33%
Influenza Like Illness: 4 people, 13.33%
Head Injury: 3 people, 10.00%
Chest Pain: 3 people, 10.00%
Depression: 3 people, 10.00%
Fatigue (feeling of tiredness): 3 people, 10.00%

What are the existing conditions these people have? *

Fibromyalgia (a long-term condition which causes pain all over the body): 4 people, 13.33%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 3 people, 10.00%
Neuralgia (pain in one or more nerves): 2 people, 6.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 6.67%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 6.67%
Depression: 2 people, 6.67%
Osteopenia (a condition where bone mineral density is lower than normal): 2 people, 6.67%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 1 person, 3.33%
Exostosis (formation of new bone on the surface of a bone): 1 person, 3.33%
Complex Regional Pain Syndrome (long lasting pain condition most often affecting one of the limbs (arms, legs, hands, or feet)): 1 person, 3.33%

* Approximation only. Some reports may have incomplete information.

Do you take Levoxyl and have Psychotic disorder?

- Check whether Psychotic disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Levoxyl:

Levoxyl (25,178 reports)

Browse all side effects of Levoxyl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Psychotic disorder:

Psychotic disorder (1,233 drugs)

Browse all the conditions that are associated with Psychotic disorder:

Psychotic disorder (1,471 conditions)

Related publications that referenced our studies

Kapoor S, "Influence of Vitamin D Consumption and Levels on the Development of Psychiatric Disorders", Lee, Y. J., & Park, K. (2018). Secondary Raynaud’s Phenomenon and Skin Necrosis of Toes in the Paraplegic Patient with Hypertension.?Drug safety-case reports,?5(1), 7., 2014 Aug .
Kapoor S, "Influence of Vitamin D Consumption and Levels on the Development of Psychiatric Disorders", Lee, Y. J., & Park, K. (2018). Secondary Raynaud’s Phenomenon and Skin Necrosis of Toes in the Paraplegic Patient with Hypertension.?Drug safety-case reports,?5(1), 7., 2014 Aug .

How the study uses the data?

The study uses data from the FDA. It is based on levothyroxine sodium (the active ingredients of Levoxyl) and Levoxyl (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.